GSK plc
GSK
Classifica tra le azioni
#9210
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
Prezzo delle azioni
$25.09
Ultima sincronizzazione: 2026-10-21
Capitalizzazione di mercato
$1.01B
Variazione (1 giorno)
-1.20%
Variazione (1 anno)
15.64%
Paese
GB
Scambia GSK plc (GSK)
Categoria
Healthcare
Storico del prezzo dell'azione per GSK plc (GSK)
Prezzo di chiusura più alto: $24.09 il 2026-10-01
Prezzo di chiusura più basso: $25.32 il 2003-06-01
Prezzo di chiusura più basso: $25.32 il 2003-06-01
Storico del prezzo dell'azione di GSK plc dal 2003 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2026 (TTM) | 7.12% |
| 2025 | 40.68% |
| 2024 | -6.72% |
| 2023 | 2.22% |
| 2022 | -32.53% |
| 2021 | 14.18% |
| 2020 | -19.98% |
| 2019 | 22.69% |
| 2018 | 7.60% |
| 2017 | -6.71% |
| 2016 | -7.21% |
| 2015 | -8.36% |
| 2014 | -15.89% |
| 2013 | 20.20% |
| 2012 | -3.30% |
| 2011 | 14.36% |
| 2010 | -6.93% |
| 2009 | 19.05% |
| 2008 | -31.41% |
| 2007 | -1.01% |
| 2006 | 2.88% |
| 2005 | 12.26% |
| 2004 | 1.24% |
| 2003 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $1.27K | 56.64% |
US
|
|
| $257.61 | 33.52% |
US
|
|
| $284.48 | 24.40% |
US
|
|
| $149.84 | 71.03% |
US
|
|
| $482.98 | 31.03% |
CH
|
